The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells
- PMID: 20197768
- PMCID: PMC2844039
- DOI: 10.1038/sj.bjc.6605591
The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells
Abstract
Background: The G-protein-coupled formylpeptide receptor (FPR) that mediates chemotaxis of phagocytic leucocytes induced by bacterial and host-derived chemotactic peptides is selectively expressed by highly malignant human gliomas and contributes to tumour growth and angiogenesis. As invasion of surrounding normal tissues is one of the important features of tumour malignancy, we investigated the function of FPR in the invasive behaviour of human glioblastoma cells.
Methods: Cells (FPR(+) and FPR(-)) were isolated by single-cell cloning from a human glioblastoma cell line U-87MG. The FPR expression was assayed by flow cytometry and reverse transcription PCR. The function of FPR was investigated by chemotaxis and calcium flux induced by FPR agonist fMLF. Tumour cell motility was assayed by a wound-healing model in vitro. The growth and invasive phenotype were observed with subcutaneous implantation of tumour cells in nude mice. Over-expression of FPR in FPR(-) cells was performed by transfection of a plasmid vector-containing human FPR gene.
Results: One of the glioma clones F9 that expressed high level of FPR showed a more 'motile' phenotype in vitro as compared with a clone G3 without FPR expression. Although F9 and G3 clones both formed subcutaneous tumours in nude mice, only F9 tumours invaded surrounding mouse connective tissues. Over-expression of FPR in G3 clone (G3F) increased the cell motility in vitro and the capacity of the cells to form more rapidly growing and invasive tumours in nude mice. We further found that, in addition to supernatant of necrotic tumour cells, foetal calf serum and human serum used in culture media contained FPR agonist activity and increased the motility of FPR-expressing glioblastoma cells.
Conclusion: The expression of FPR is responsible for increased motility of human glioblastoma cells and their formation of highly invasive tumours.
Figures






Similar articles
-
Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.J Natl Cancer Inst. 2005 Jun 1;97(11):823-35. doi: 10.1093/jnci/dji142. J Natl Cancer Inst. 2005. PMID: 15928303
-
Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation.Carcinogenesis. 2009 Feb;30(2):348-55. doi: 10.1093/carcin/bgn266. Epub 2008 Nov 26. Carcinogenesis. 2009. PMID: 19037090 Free PMC article.
-
Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR.J Neurooncol. 2008 Jan;86(1):47-53. doi: 10.1007/s11060-007-9443-y. Epub 2007 Jul 5. J Neurooncol. 2008. PMID: 17611713
-
Biologically active peptides interacting with the G protein-coupled formylpeptide receptor.Protein Pept Lett. 2007;14(9):846-53. doi: 10.2174/092986607782110211. Protein Pept Lett. 2007. PMID: 18045224 Review.
-
Receptor "hijacking" by malignant glioma cells: a tactic for tumor progression.Cancer Lett. 2008 Aug 28;267(2):254-61. doi: 10.1016/j.canlet.2008.03.014. Epub 2008 Apr 22. Cancer Lett. 2008. PMID: 18433988 Free PMC article. Review.
Cited by
-
Application of small molecule FPR1 antagonists in the treatment of cancers.Sci Rep. 2020 Oct 14;10(1):17249. doi: 10.1038/s41598-020-74350-z. Sci Rep. 2020. PMID: 33057069 Free PMC article.
-
An Exploration of the Tumor Microenvironment Identified a Novel Five-Gene Model for Predicting Outcomes in Bladder Cancer.Front Oncol. 2021 May 3;11:642527. doi: 10.3389/fonc.2021.642527. eCollection 2021. Front Oncol. 2021. PMID: 34012914 Free PMC article.
-
The G-protein coupled chemoattractant receptor FPR2 promotes malignant phenotype of human colon cancer cells.Am J Cancer Res. 2016 Nov 1;6(11):2599-2610. eCollection 2016. Am J Cancer Res. 2016. PMID: 27904774 Free PMC article.
-
The leukocyte chemotactic receptor FPR1 is functionally expressed on human lens epithelial cells.J Biol Chem. 2012 Nov 23;287(48):40779-92. doi: 10.1074/jbc.M112.411181. Epub 2012 Sep 25. J Biol Chem. 2012. PMID: 23012360 Free PMC article.
-
Microarray expression profiling identifies genes, including cytokines, and biofunctions, as diapedesis, associated with a brain metastasis from a papillary thyroid carcinoma.Am J Cancer Res. 2016 Oct 1;6(10):2140-2161. eCollection 2016. Am J Cancer Res. 2016. PMID: 27822408 Free PMC article.
References
-
- Babbin BA, Lee WY, Parkos CA, Winfree LM, Akyildiz A, Perretti M, Nusrat A (2006) Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem 281(28): 19588–19599 - PubMed
-
- Cheng N, He R, Tian J, Dinauer MC, Ye RD (2007) A critical role of protein kinase C delta activation loop phosphorylation in formyl-methionyl-leucyl-phenylalanine-induced phosphorylation of p47(phox) and rapid activation of nicotinamide adenine dinucleotide phosphate oxidase. J Immunol 179(11): 7720–7728 - PubMed
-
- Chintala SK, Sawaya R, Aggarwal BB, Majumder S, Giri DK, Kyritsis AP, Gokaslan ZL, Rao JS (1998) Induction of matrix metalloproteinase-9 requires a polymerized actin cytoskeleton in human malignant glioma cells. J Biol Chem 273(22): 13545–13551 - PubMed
-
- De Paulis A, Ciccarelli A, de Crescenzo G, Cirillo R, Patella V, Marone G (1996) Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine. J Allergy Clin Immunol 98(1): 152–164 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous